Atlas Trials

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Clinical trial NCT05650203 · WITHDRAWN

Trial details

NCT number
NCT05650203
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Primary Condition: Advanced Tumors
Start date
2023-03-31
Primary completion
2025-10-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.